文献速递乳房整形与再造显微修复重建创面修复

肥胖患者腹部游离皮瓣显微乳房再造的并发症与满意度

Microsurgical Breast Reconstruction in the Obese Patient Using Abdominal Flaps: Complication Profile and Patient Satisfaction.
PubMed 文献 · Ann Plast Surg · 2020-01-01

该回顾性研究比较肥胖与非肥胖患者接受腹部游离皮瓣显微乳房再造的并发症率和满意度,随访6至112个月。肥胖组皮瓣坏死、计划外再手术及腹壁膨出/疝发生率更高,但Breast-Q各维度满意度与BMI无显著差异,肥胖不应视为绝对禁忌。

要点

  • 肥胖组乳房皮瓣坏死率19.3% vs 7.7%,计划外再手术率38.6% vs 21.1%。
  • 肥胖组需手术干预的严重伤口并发症及腹壁疝/膨出更高。
  • Breast-Q满意度各维度与BMI无显著差异,但问卷应答率仅30%。

核心结论

  • 肥胖与显微乳房再造后伤口并发症、再手术和腹壁膨出风险升高相关,但患者满意度仍较高。
  • 高BMI不应被视为显微乳房再造的绝对禁忌证,但应告知相对风险。

研究设计与样本

  • 回顾性队列研究,纳入单术者15年间所有显微乳房再造患者,分为肥胖组(BMI≥30 kg/m²)与非肥胖组。
  • 共109例患者、149侧乳房再造,平均年龄49岁,随访6至112个月(中位19个月)。
  • 肥胖组59例,非肥胖组52例;两组中位年龄、随访时间、病理类型、化疗或放疗史及吸烟史无显著差异。

主要发现

  • 肥胖组乳房皮瓣坏死发生率19.3% vs 非肥胖组7.7%(P<0.01)。
  • 肥胖组计划外再手术率38.6% vs 非肥胖组21.1%(P<0.01)。
  • 显微外科并发症或皮瓣丢失风险两组无显著差异(7.0% vs 3.8%,P=0.21)。
  • 总体伤口并发症两组无差异,但肥胖组需手术干预的严重伤口并发症更高(15.8% vs 3.8%,P<0.01)。
  • 肥胖组腹壁疝或膨出发生率10.5% vs 非肥胖组0%(P=0.03)。

关键数值与推荐

  • 肥胖定义:BMI≥30 kg/m²。

临床怎么用

  • 术前应告知肥胖患者伤口并发症、再手术及腹壁膨出风险相对较高。
  • 肥胖不应作为显微乳房再造的绝对禁忌,但需个体化评估并加强术后伤口与腹壁监测。

局限性

  • 单术者回顾性研究,样本量有限。
  • Breast-Q问卷应答率仅30%,满意度结果可能存在应答偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The obesity epidemic has led to larger numbers of obese patients seeking breast reconstruction. The aim of this study was to compare complication rates and patient satisfaction between obese and nonobese women undergoing autologous breast reconstruction using abdominal free flaps. METHODS: The records of all patients who underwent microsurgical breast reconstruction by one surgeon for 15 years were reviewed. Patients were divided into obese (body mass index [BMI] ≥ 30 kg/m and nonobese groups. Demographic data, medical and smoking history, cancer type and treatments, surgical details, and complications were recorded. Breast-Q surveys were mailed to all patients, and satisfaction ratings were compared between obese and nonobese patients. RESULTS: There were 109 patients and 149 breast reconstructions, with a mean age of 49 years. Follow-up ranged from 6 to 112 months (median = 19 months). There were 59 patients in the obese group and 52 in the nonobese group. The 2 groups did not differ significantly in median age, follow-up, pathology type, presence of chemotherapy or radiation, or smoking history. Obese group had a higher incidence of mastectomy flap necrosis (19.3% vs 7.7%, P < 0.01) and a higher rate of unplanned reoperations (38.6% vs 21.1%, P < 0.01). Obesity was not associated with a higher risk of microsurgical complications or flap loss (7.0% vs 3.8%, P = 0.21). Overall wound complications did not differ between the groups, but the obese group had a higher rate of severe wound complications requiring operative intervention (15.8% vs 3.8%, P < 0.01). The obese group had a higher incidence of hernia or bulge (10.5% vs 0%, P = 0.03). Thirty-three patients returned completed surveys (response rate of 30%). There was no statistically significant difference in any Breast-Q category associated with BMI. CONCLUSIONS: Obesity was associated with higher rates of wound complications, reoperation, and abdominal bulge after microsurgical breast reconstruction. However, patient satisfaction remained high. Patients should be counseled regarding their relative risks, but high BMI should not be considered an absolute contraindication for microsurgical breast reconstruction.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Boczar D, Huayllani MT, Forte AJ, et al. Microsurgical Breast Reconstruction in the Obese Patient Using Abdominal Flaps: Complication Profile and Patient Satisfaction. Ann Plast Surg. 2020. PMID: 32028469. doi:10.1097/SAP.0000000000002284

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。